• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

More frequent screening after prostate cancer treatment not linked to improved survival

Bioengineer by Bioengineer
June 4, 2018
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

CHICAGO — Prostate cancer patients who were monitored more frequently after treatment did not live significantly longer than patients who were monitored once a year, according to study findings led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher.

At the 2018 American Society of Clinical Oncology Annual Meeting in Chicago, researchers presented findings on Friday, June 1, from an analysis of data from nearly 10,500 prostate cancer patients in the United States from 2005 to 2010. The study's primary goal was to determine if more frequent monitoring with the prostate-specific antigen test after treatment improved patients' long-term survival. The researchers found that survival risk was not significantly different for patients who had PSA monitoring every three months compared with patients who had monitoring once a year.

"This suggests that for prostate cancer patients, once-a-year monitoring may be enough," said UNC Lineberger's Ronald C. Chen, MD, MPH, associate professor in the UNC School of Medicine Department of Radiation Oncology, who was the study's first author. "This is not a surprising finding because prostate cancer is often a slow-growing disease."

After completing treatment for prostate cancer, patients need routine monitoring to detect a potential recurrence of the cancer and get treated early, Chen said, with the goal of improving long-term survival. For patients who have finished either surgery or radiation, the PSA test is used to check regularly to look for recurrence. However, Chen said guidelines have differed as to how often the test is needed.

"If more frequent testing does not help patients live longer, then it can actually harm the patient in terms of the cost of testing, and causing stress and anxiety," said University of North Carolina School of Medicine's Ramsankar Basak, PhD, a study co-author. "We hope that results of this study will help change future guidelines on monitoring of prostate cancer patients after treatment."

###

In addition to Chen and Basak, the other authors included Zahed Mohammed, Jessica R. Schumacher, Amanda B. Francescatti, Amanda Cuddy, George J. Chang, Benjamin D. Kozower, Caprice Christian Greenberg, Anne McCarthy, Stephen B. Edge, and David P. Winchester.

The study was supported by the Patient-Centered Outcomes Research Institute.

Media Contact

Bill Schaller
[email protected]
617-233-5507

http://cancer.med.unc.edu/

http://unclineberger.org/news/prostate-cancer-treatment-followup

Share12Tweet7Share2ShareShareShare1

Related Posts

miR-32-5p Blocks c-MYC, Triggers Breast Cancer Cell Death

miR-32-5p Blocks c-MYC, Triggers Breast Cancer Cell Death

August 6, 2025
blank

PELP1 Drives Ovarian Cancer Growth, Spread, Angiogenesis

August 6, 2025

HyperArc Stereotactic Radiotherapy: Lung Brain Metastasis Evaluation

August 6, 2025

New Study Enhances and Refines 3D Models to Advance Colorectal Cancer Research

August 6, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Neuropsychiatric Risks Linked to COVID-19 Revealed

    74 shares
    Share 30 Tweet 19
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    46 shares
    Share 18 Tweet 12
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Stable 4.8V Cathodes via Supersaturated High-Valence Design

Hypoxia Improves Neurodegeneration, Movement in Parkinson’s Mice

Forensic Age Estimation in Southwestern Chinese Adolescents

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.